Research Grants 9 show all


$2.4M
2012

$407.1K
2014

$1.4M
2015

$2.9M
2016

$1.1M
2017

Patents 193show all

  • 65
    C07H - Sugars
  • 62
    C07D - Heterocyclic compounds
  • 40
    C07C - Acyclic or carbocyclic compounds
  • 38
    A61K - Preparations for medical, dental, or toilet purposes
  • 36
    Y02A - Technologies for adaptation to climate change
  • 7
    C07K - Peptides
  • 6
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 4
    C07B - General methods of organic chemistry
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 1
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

Clinical Trials 25show all

14Phase 39Phase 12Other

SEC Filings show all


66
8-K

15
10-Q

5
10-K

5
D

1
S-1

Contact Information

South San Francisco, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-03-22$30,683,703$18,905,707Equity
2010-04-19$56,413,706$35,360,873Equity
2006-10-02Unknown Unknown Other (Paper Filing)

Key Executives

  • J. Kevin Judice
    Executive Officer, Director
  • Jon B. Bruss
    Executive Officer
  • John C. Doyle
    Executive Officer
  • John F. Hollway
    Executive Officer
  • Heinz E. Moser
    Executive Officer
  • Bryan E. Roberts
    Director
  • Scott Rocklage
    Director
  • Kenneth Nussbacher
    Director
  • Camille D. Samuels
    Director
  • Thomas King
    Director
  • Christopher Walsh
    Director
  • Robert More
    Director
  • Kenneth J. Hillan
    Executive Officer, Director
  • Becki Filice
    Executive Officer
  • Christine Welch
    Executive Officer
  • Dennis Hom
    Executive Officer
  • Bryan Roberts
    Director
  • John Doyle
    Director
  • Camille Samuels
    Director
  • Troy Cox
    Director